Header

UZH-Logo

Maintenance Infos

Intralymphatische Immuntherapie: Eine sichere und effektive Methode zur Desensibilisierung der caninen atopischen Dermatitis


Fischer, N; Rostaher, A; Favrot, C (2016). Intralymphatische Immuntherapie: Eine sichere und effektive Methode zur Desensibilisierung der caninen atopischen Dermatitis. Schweizer Archiv für Tierheilkunde, 158(9):646-652.

Abstract

Allergen-specific immunotherapy (ASIT) is the only etiologic treatment of atopic dermatitis in dogs. In humans it has been shown that intralymphatic immunotherapy (ILIT) enhanced efficacy and patient compliance and reduced treatment time from 3 years to 8 weeks. As only safety data have been published yet, the aim of this study was to evaluate the clinical efficacy of ILIT in dogs. 20 atopic dogs underwent ILIT with alum-precipitated allergens administered every 4 weeks for 3 to 7 times in the popliteal lymph node. Pruritus (Hill score), CADESI (canine atopic dermatitis severety index), concurrent medications and adverse reactions were recorded initially and every 4 weeks for a total period of 24 weeks. The observed clinical response was good in 12/20 (60%) patients and improvement could be seen in some dogs already after 4 weeks. The median number of injections was 5.6. All dogs tolerated the procedure well and no adverse effects were recognized during or after ILIT. Therefore ILIT should be regarded as a safe alternative to subucaneous ASIT, enabling a faster clinical improvement with the same response rate.

Abstract

Allergen-specific immunotherapy (ASIT) is the only etiologic treatment of atopic dermatitis in dogs. In humans it has been shown that intralymphatic immunotherapy (ILIT) enhanced efficacy and patient compliance and reduced treatment time from 3 years to 8 weeks. As only safety data have been published yet, the aim of this study was to evaluate the clinical efficacy of ILIT in dogs. 20 atopic dogs underwent ILIT with alum-precipitated allergens administered every 4 weeks for 3 to 7 times in the popliteal lymph node. Pruritus (Hill score), CADESI (canine atopic dermatitis severety index), concurrent medications and adverse reactions were recorded initially and every 4 weeks for a total period of 24 weeks. The observed clinical response was good in 12/20 (60%) patients and improvement could be seen in some dogs already after 4 weeks. The median number of injections was 5.6. All dogs tolerated the procedure well and no adverse effects were recognized during or after ILIT. Therefore ILIT should be regarded as a safe alternative to subucaneous ASIT, enabling a faster clinical improvement with the same response rate.

Statistics

Citations

2 citations in Web of Science®
1 citation in Scopus®
Google Scholar™

Altmetrics

Downloads

81 downloads since deposited on 29 Sep 2016
76 downloads since 12 months
Detailed statistics

Additional indexing

Other titles:Intralymphatic immunotherapy: An effective and safe alternative route for canine atopic dermatitis
Item Type:Journal Article, refereed, original work
Communities & Collections:05 Vetsuisse Faculty > Veterinary Clinic > Department of Small Animals
Dewey Decimal Classification:570 Life sciences; biology
630 Agriculture
Language:German
Date:September 2016
Deposited On:29 Sep 2016 12:12
Last Modified:08 Dec 2017 20:27
Publisher:Gesellschaft Schweizer Tierärztinnen und Tierärzte
ISSN:0036-7281
Publisher DOI:https://doi.org/10.17236/sat00085
PubMed ID:27655164

Download

Download PDF  'Intralymphatische Immuntherapie: Eine sichere und effektive Methode zur Desensibilisierung der caninen atopischen Dermatitis'.
Preview
Content: Published Version
Filetype: PDF
Size: 412kB
View at publisher